Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CSU”

172 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 172 results

Early research (Phase 1)Study completedNCT04538794
What this trial is testing

CDX-0159 in Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Celldex Therapeutics 45
Not applicableLooking for participantsNCT07425639
What this trial is testing

ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Allergic Asthma
Celltrion HealthCare France 225
Testing effectiveness (Phase 2)Study completedNCT05936567
What this trial is testing

Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

Who this might be right for
UrticariaChronic Spontaneous UrticariaChronic Idiopathic Urticaria+3 more
Incyte Corporation 136
Large-scale testing (Phase 3)Study completedNCT02372604
What this trial is testing

Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Hospices Civils de Lyon 15
Not applicableStudy completedNCT01637116
What this trial is testing

Profiling Urticaria for the Identification of Subtypes

Who this might be right for
Non-autoreactive Chronic Spontaneous UrticariaAutoimmune Chronic Spontaneous UrticariaAutoreactive, Non-autoimmune Chronic Spontaneous Urticaria
Marcus Maurer 195
Large-scale testing (Phase 3)Study completedNCT03580356
What this trial is testing

A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 1,078
Testing effectiveness (Phase 2)WithdrawnNCT04827589
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Gilead Sciences
Not applicableActive Not RecruitingNCT06991608
What this trial is testing

Compare Digital Disease Monitoring of Patients With csU (Telemedicine to Face-to-Face Visits) in Germany

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 116
Early research (Phase 1)Study completedNCT07230418
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes

Who this might be right for
Chronic Spontaneous Urticaria
Chengdu Suncadia Medicine Co., Ltd. 82
Post-approval studies (Phase 4)Study completedNCT03183024
What this trial is testing

Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody

Who this might be right for
Chronic Idiopathic Urticaria
Jonathan A. Bernstein, MD 12
Early research (Phase 1)Ended earlyNCT04444466
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants

Who this might be right for
Healthy Study ParticipantsChronic Spontaneous Urticaria
UCB Biopharma SRL 40
Testing effectiveness (Phase 2)Study completedNCT03137069
What this trial is testing

GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

Who this might be right for
Urticaria
Genentech, Inc. 134
Not applicableAvailableNCT04776694
What this trial is testing

Compassionate Use or Expanded Access of Dupilumab

Who this might be right for
Type 2 Inflammatory Disorders
Regeneron Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT00199251
What this trial is testing

Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria

Who this might be right for
Urticaria
J. Uriach and Company 300
Post-approval studies (Phase 4)Study completedNCT00536380
What this trial is testing

Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849)

Who this might be right for
Chronic Idiopathic Urticaria
Organon and Co 314
Not applicableEnrolling By InvitationNCT07632040
What this trial is testing

Pseudoallergen-Free and Low-Histamine Diet in Adolescents With Chronic Spontaneous Urticaria

Who this might be right for
Pediatric Chronic Spontaneous Urticaria
Istanbul University 120
Testing effectiveness (Phase 2)Ended earlyNCT03693625
What this trial is testing

Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study

Who this might be right for
Urticaria
Genentech, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT05107115
What this trial is testing

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

Who this might be right for
Chronic Spontaneous Urticaria
Sanofi 160
Early research (Phase 1)UnknownNCT04175704
What this trial is testing

Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
United BioPharma 32
Early research (Phase 1)Study completedNCT06072157
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria

Who this might be right for
Healthy ParticipantsChronic Spontaneous Urticaria
Allakos Inc. 136
Next Page